Safety and Efficacy of Apixaban versus warfarin in patients with atrial fibrillation or Venous Thromboembolism and End-Stage renal disease on hemodialysis: A systematic review and meta-analysis

BACKGROUND: Warfarin is traditionally the drug of choice for stroke prophylaxis or treatment of venous thromboembolism in patients with end-stage renal disease (ESRD) on hemodialysis as data on apixaban use is scarce. We aimed to assess the safety and efficacy of Apixaban in patients with ESRD on he...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Indian Pacing Electrophysiol J
Main Authors: Murtaza, Ghulam, Turagam, Mohit K., Garg, Jalaj, Boda, Urooge, Akella, Krishna, Velagapudi, Poonam, Natale, Andrea, Gopinathannair, Rakesh, Lakkireddy, Dhanunjaya
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2021
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8263313/
https://ncbi.nlm.nih.gov/pubmed/33866017
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ipej.2021.04.002
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki